Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00319696
Status:
COMPLETED
Last Update Posted:
2019-01-08
First Post:
2006-04-27
Brief Title:
Bosentan in Digital Ulcers
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
Long-term Bosentan Open Label Extension of the AC-052-331 Study in Systemic Sclerosis Patients With Ischemic Digital Ulcers
Status:
COMPLETED
Status Verified Date:
2018-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RAPIDS 2 OL
Brief Summary:
The aim of the study is to collect long-term efficacy tolerability and safety data of bosentan in Systemic Sclerosis SSc patients suffering from ischemic digital ulcers DUs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None